The Valley Desk

NCT00003425 · Interventional trial

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

Overall registry status Completed

Phase 1 · Phase 2

Conditions Breast Cancer, Leukemia, Lymphoma, Neuroblastoma, Ovarian Cancer, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov